Skip to main content

WATERS CORP

corporate_fare Company Profile

WATERS CORP

WAT·NYSE·Life Sciences·CIK 0001000697

Waters Corporation is a global leader in analytical instruments and software, with over 65 years of innovation in chromatography, mass spectrometry, and thermal analysis for life, materials, and food sciences. The company primarily designs, manufactures, sells, and services high-performance liquid chromatography (HPLC), ultra-performance liquid chromatography (UPLC), and mass spectrometry (MS) technology systems. These systems are often used together as integrated LC-MS instrument systems with common software platforms. Waters also provides support products, including chromatography columns, other consumable products, and post-warranty service plans. The company's products are utilized by pharmaceutical, clinical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers for research and development, quality assurance, and other laboratory applications. LC is a standard technique used across industries to detect, identify, monitor, measure, and purify compounds. MS technology, often with chromatography, is employed in drug discovery and development, clinical trial testing, proteomics, nutritional safety analysis, and environmental testing. Additionally, Waters designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments through its TA Instruments (TA) product line. These instruments predict the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, healthcare products, and life science research. Waters Corporation also develops and supplies advanced software-based products that interface with its own instruments and those from other manufacturers. Waters Corporation, a Delaware corporation organized in 1991, is a holding company for its operating subsidiary, Waters Technologies Corporation, and became publicly traded in November 1995.

WATERS CORP (NYSE:WAT) is a publicly traded company in the Life Sciences sector. Wiseek monitors WAT SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Waters Corp's Acquisition Financing: $4 Billion Term Loan Secured for Reverse Morris Trust with BD SpinCo
  • Waters Corp to Acquire BD's Biosciences and Diagnostic Solutions Business in $17.5B Reverse Morris Trust

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$3.17B
Net Income
$642.63M
Diluted EPS
$10.76
Op. Cash Flow
$652.55M
Free Cash Flow
$539.81M
Gross Profit
$1.88B
Operating Income
$802.59M
Cash & Equivalents
$587.83M
Total Debt
$947.45M
Debt / Equity
0.37×
Net Margin
20.3%
Shares Outstanding
59.55M sh
Source: 10-K · filed 2026-02-23 · accession 0001193125-26-062604
$355.53
52-week range · as of 2026-05-12 $275.05 – $414.15
Market cap
$34.91B
Volume
780.9K (0.7× avg)
3-mo avg 1.1M
Live data · 2026-06-14 07:03 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed WAT - Filings & News (Page 2)

WAT
Jan 12, 2026, 4:37 PM EST
Filing Type: 425
Importance Score:
8
Price at Filing: $393.68
Real-time Price: $355.53 info
Change: -$38.15 (-10%) info
Market Cap: $34.908B info
WAT
Jan 05, 2026, 7:31 AM EST
Filing Type: 425
Importance Score:
9
Price at Filing: $383.63
Real-time Price: $355.53 info
Change: -$28.10 (-7%) info
Market Cap: $34.908B info